SPON2 might be a potential independent prognostic biomarker for pulmonary ADC, the potential clinical value of detecting SPON2 levels in ADC patients’ diagnosis and treatment should be further confirmed in randomized controlled trials and prospective studies. Here, SPON2 is linked to AIDS dementia complex.